Резюме
Українці щойно почали звикати до життя в умовах закінчення пандемії COVID-19, як на горизонті з’являється нова небезпека, а саме гарячка Західного Нілу (ГЗН). Так, в Україні на початку серпня 2024 року було зареєстровано 41 лабораторно підтверджений випадок захворювання на гарячку Західного Нілу, а в цілому з початку поточного року, за даними центру громадського здоров’я від 30.08.2024 р., — близько 50 випадків. Подальше поширення ГЗН пов’язане зі змінами клімату на планеті й ареалу мешкання, насамперед, комарів. Це стосується і нашої країни.
Ukrainians have just begun to get used to life in the conditions of the end of the COVID-19 pandemic, when a new danger appears on the horizon, namely West Nile fever. Thus, at the beginning of August 2024, forty-one laboratory confirmed cases of West Nile fever were registered in Ukraine and in general since the beginning of the current year, according to the data of the public health center as of August 30, 2024, — about 50 cases. The further spread of West Nile fever is associated with changes in the planet’s climate and habitat, primarily of mosquitoes. This also applies to our country.
Список литературы
1. General Questions About West Nile Virus. www.cdc.gov. 19 October 2017. Archived from the original on 26 October 2017. Retrieved 26 October 2017.
2. Symptoms, Diagnosis, & Treatment. www.cdc.gov. 15 January 2019. Archived from the original on 26 October 2017. Retrieved 15 January 2019.
3. West Nile virus. World Health Organization. July 2011. Archived from the original on 18 October 2017. Retrieved 28 October 2017.
4. Final Cumulative Maps and Data | West Nile Virus | CDC. www.cdc.gov. 24 October 2017. Archived from the original on 27 October 2017. Retrieved 28 October 2017.
5. Gompf, Sandra. West Nile Virus. Medicine Net. MedicineNet Inc. Retrieved 15 January 2019.
6. Symptoms, Diagnosis, & Treatment. Centers for Disease Control and Prevention. USA.gov. 2018-12-10. Retrieved 15 January 2019.
7. West Nile virus. Mayoclinic. Mayo Foundation for Medical Education and Research (MFMER). Retrieved 15 January 2019.
8. Olejnik E. Infectious adenitis transmitted by Culex molestus. Bull Res Counc Isr. 1952;2:210-1.
9. Flores Anticona EM, Zainah H, Ouellette DR, Johnson LE. Two case reports of neuroinvasive west nile virus infection in the critical care unit. Case Reports in Infectious Diseases. 2012:1-4. doi: 10.1155/2012/839458. PMC 3433121. PMID 22966470.
10. Carson PJ, Konewko P, Wold KS, et al. Long-term clinical and neuropsychological outcomes of West Nile virus infection (PDF). Cli-nical Infectious Diseases. 2006;43(6):723-30. doi: 10.1086/506939. PMID 16912946. S2CID 2765866. Archived (PDF) from the original on 2022-10-09.
11. Mojumder DK, Agosto M, Wilms H, et al. Is initial preservation of deep tendon reflexes in West Nile Virus paralysis a good prognostic sign? Neurology Asia. March 2014;19(1):93-97. PMC 4229851. PMID 25400704.
12. Smith RD, Konoplev S, DeCourten-Myers G, Brown T. West Nile virus encephalitis with myositis and orchitis. Hum. Pathol. February 2004;35(2):254-8. doi: 10.1016/j.humpath.2003.09.007. PMID 14991545.
13. Anninger WV, Lomeo MD, Dingle J, Epstein AD, Lubow M. West Nile virus-associated optic neuritis and chorioretinitis. Am. J. Ophthalmol. 2003;136(6):1183-5. doi: 10.1016/S0002-9394(03)00738-4. PMID 14644244.
14. Paddock CD, Nicholson WL, Bhatnagar J, et al. Fatal hemorrhagic fever caused by West Nile virus in the United States. Clinical Infectious Diseases. June 2006;42(11):1527-35. doi: 10.1086/503841. PMID 16652309.
15. Shaikh S, Trese MT. West Nile virus chorioretinitis. Br J Ophthalmol. 2004;88(12):1599-60. doi: 10.1136/bjo.2004.049460. PMC 1772450. PMID 15548822.
16. Lobigs M, Diamond MS. Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex. Expert Rev Vaccines. 2012;11(2):177-87. doi: 10.1586/erv.11.180. PMC 3337329. PMID 22309667.
17. Home — PMC — NCBI. www.ncbi.nlm.nih.gov. Retrieved 2022-06-24.
18. Paz, Shlomit. Climate change impacts on West Nile virus transmission in a global context. Philosophical Transactions of the Royal Society B: Biological Sciences. 2015;370(1665):20130561. doi: 10.1098/rstb.2013.0561. ISSN 0962-8436. PMC 4342965. PMID 25688020.
19. Vogels Chantal Bf, Göertz Giel P, Pijlman Gorben P, Koenraadt Constantianus Jm. Vector competence of European mosquitoes for West Nile virus. Emerging Microbes & Infections. 2017;6(11):e96. Doi: 10.1038/emi.2017.82. ISSN 2222-1751. PMC 5717085. PMID 29116220.
20. Kilpatrick AM. Globalization, land use, and the invasion of West Nile virus. Science. 2011;334(6054):323-327. Bibcode: 2011Sci...334..323K. doi: 10.1126/science.1201010. PMC 3346291. PMID 22021850.
21. West Nile virus. Mayo Clinic. Archived from the original on 26 October 2017. Retrieved 25 October 2017.
22. Schneider BS, Soong L, Girard YA, Campbell G, Mason P, Higgs S. Potentiation of West Nile encephalitis by mosquito feeding. Viral Immunol. 2006;19(1):74-82. doi: 10.1089/vim.2006.19.74. PMID 16553552. S2CID 37464180.
23. Wasserman HA, Singh S, Champagne DE. Saliva of the Yellow Fever mosquito, Aedes aegypti, modulates murine lymphocyte function. Parasite Immunol. 2004;26(6-7):295-306. doi: 10.1111/j.0141-9838.2004.00712.x. PMID 15541033. S2CID 32742815.
24. Limesand KH, Higgs S, Pearson LD, Beaty BJ. Effect of mosquito salivary gland treatment on vesicular stomatitis New Jersey virus replication and interferon alpha/beta expression in vitro. J. Med. Entomol. 2003;40(2):199-205. doi: 10.1603/0022-2585-40.2.199. PMID 12693849. S2CID 85624297.
25. Wanasen N, Nussenzveig RH, Champagne DE, Soong L, Higgs S. Differential modulation of murine host immune response by salivary gland extracts from the mosquitoes Aedes aegypti and Culex quinquefasciatus. Med. Vet. Entomol. 2004;18(2):191-9. doi: 10.1111/j.1365-2915.2004.00498.x. PMID 15189245. S2CID 42458052.
